Rapid Testing

Medical professionals can establish a higher Point of Care testing standard when they institute Rapid testing in urgent care situations. These test kits improve the customer experience with effective point of care diagnostics, treatment and management.

Doctors, lab technicians, nurses, hospital management, and most importantly, patients, benefit from simplified technology that is rapid, reliable and easy to use.

We are dedicated to ensuring that you have not only the right point of care diagnostics and rapid testing tools, but also the right processes in place to make significant enhancements to your decentralized testing protocols.

	DXpress™ Reader The DXpress is a small reader that works in conjunction with StatusFirst® CHF test to measure and display quantitative results for NT-proBNP. Learn more about DXpress™ Reader...
	Nanogen i-Lynx™ Reader The i-Lynx is a simple, handheld absorbance reader that connects directly to a lab’s LIS to automatically capture test results. It eliminates the manual process of inputting data, and ensures better quality control. Learn more about Nanogen i-Lynx™ Reader...

	StatusFirst® CHF NT-proBNP StatusFirst CHF is a rapid test aiding in the diagnosis of congestive heart failure providing a quantitative determination of the level of NT-proBNP in human EDTA plasma. The system has been cleared by FDA in the United States. CE self declaration in the European Union is pending.
	Nanogen Cardiac STATus® Cardiac STATus quickly and accurately uses three cardiac markers to aid in the diagnosis of acute myocardial infarction in patients experiencing chest pain. Nanogen offers Cardiac STATus in three configurations: as a stand alone Troponin I test, as a combination of Troponin I and Myoglobin or as a combination of three tests including Troponin I, Myoglobin and CK-MB.
	Nanogen Tox STATus™ Tox STATus quickly and accurately identifies a wide range of drugs of abuse in cost-effective configurations. Eleven different drugs are offered in different combinations of up to ten drugs on one panel.
	Decision Point Decision Point (available only outside the U.S.) quickly and accurately uses cardiac markers to aid in the diagnosis of acute myocardial infarction in patients experiencing chest pain. Nanogen offers Decision Point in three configurations: as a stand alone Troponin I test, as a combination of Troponin I and Myoglobin or as a combination of all three tests including Troponin I, Myoglobin and CK-MB.